Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics

Show full item record



Permalink

http://hdl.handle.net/10138/302094

Citation

Björnson , E , Packard , C J , Adiels , M , Andersson , L , Matikainen , N , Söderlund , S , Kahri , J , Sihlbom , C , Thorsell , A , Zhou , H , Taskinen , M-R & Borén , J 2019 , ' Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics ' , Journal of internal medicine , vol. 285 , no. 5 , pp. 562-577 . https://doi.org/10.1111/joim.12877

Title: Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics
Author: Björnson, E.; Packard, C. J.; Adiels, M.; Andersson, L.; Matikainen, Niina; Söderlund, S.; Kahri, J.; Sihlbom, C.; Thorsell, A.; Zhou, H.; Taskinen, M.-R.; Borén, J.
Contributor: University of Helsinki, University of Gothenburg
University of Helsinki, HUS Abdominal Center
University of Helsinki, Staff Services
University of Helsinki, HUS Internal Medicine and Rehabilitation
University of Helsinki, HUS Heart and Lung Center
Date: 2019-05
Language: eng
Number of pages: 16
Belongs to series: Journal of internal medicine
ISSN: 0954-6820
URI: http://hdl.handle.net/10138/302094
Abstract: Background Triglyceride-rich lipoproteins and their remnants have emerged as major risk factors for cardiovascular disease. New experimental approaches are required that permit simultaneous investigation of the dynamics of chylomicrons (CM) and apoB48 metabolism and of apoB100 in very low-density lipoproteins (VLDL). Methods Mass spectrometric techniques were used to determine the masses and tracer enrichments of apoB48 in the CM, VLDL1 and VLDL2 density intervals. An integrated non-steady-state multicompartmental model was constructed to describe the metabolism of apoB48- and apoB100-containing lipoproteins following a fat-rich meal, as well as during prolonged fasting. Results The kinetic model described the metabolism of apoB48 in CM, VLDL1 and VLDL2. It predicted a low level of basal apoB48 secretion and, during fat absorption, an increment in apoB48 release into not only CM but also directly into VLDL1 and VLDL2. ApoB48 particles with a long residence time were present in VLDL, and in subjects with high plasma triglycerides, these lipoproteins contributed to apoB48 measured during fasting conditions. Basal apoB48 secretion was about 50 mg day?1, and the increment during absorption was about 230 mg day?1. The fractional catabolic rates for apoB48 in VLDL1 and VLDL2 were substantially lower than for apoB48 in CM. Discussion This novel non-steady-state model integrates the metabolic properties of both apoB100 and apoB48 and the kinetics of triglyceride. The model is physiologically relevant and provides insight not only into apoB48 release in the basal and postabsorptive states but also into the contribution of the intestine to VLDL pool size and kinetics.
Subject: apolipoprotein B48
kinetics
model
remnants
stable isotope
OBESE SUBJECTS
APOLIPOPROTEIN B-48 TRANSPORT
QUANTITATION
TRIGLYCERIDE-RICH LIPOPROTEINS
OF-FUNCTION MUTATIONS
B-100
PLASMA
STABLE-ISOTOPE
C-III
A-I
3121 General medicine, internal medicine and other clinical medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Bj_rnson_et_al_ ... l_of_Internal_Medicine.pdf 2.944Mb PDF View/Open
Investigation_o ... 8_and_apoB100_kinetics.pdf 1.085Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record